These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 485196)

  • 21. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Carrier detection in Duchenne type muscular dystrophy.
    Morgan G
    Aust N Z J Med; 1974 Apr; 4(2):196-7. PubMed ID: 4528526
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modification of the calculation of risk factors in women, possible carriers of Duchenne muscular dystrophy, based on CPK levels].
    Villamar López M; Azpeitia González J; Ayuso García C; Fernández García E; Benítez Ortiz J
    An Esp Pediatr; 1992 Sep; 37(3):191-4. PubMed ID: 1443913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier detection in Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Miller SE; Hull KL; Appel SH
    N Engl J Med; 1976 Jan; 294(4):193-8. PubMed ID: 1244534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum myoglobin in muscular dystrophy and carrier detection.
    Nicholson LV
    J Neurol Sci; 1981 Sep; 51(3):411-26. PubMed ID: 7276986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum creatine phosphokinase in normal newborns.
    Gilboa N; Swanson JR
    Arch Dis Child; 1976 Apr; 51(4):283-5. PubMed ID: 1275541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 30. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis.
    Emery AE
    Br Med Bull; 1980 May; 36(2):117-22. PubMed ID: 7020836
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women.
    Bundey S; Crawley JM; Edwards JH; Westhead RA
    J Med Genet; 1979 Apr; 16(2):117-21. PubMed ID: 379337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Echoscopic diagnosis of the heterozygote carrier state in Duchenne's muscular dystrophy].
    Krasil'nikov VV; Lazebnik TA; Prokof'ev GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):18-9. PubMed ID: 3066080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making the most of multiple measurements in estimating carrier probability in Duchenne muscular dystrophy: the Bayesian incorporation of repeated measurements using logistic discrimination.
    Percy ME; Andrews DF; Brasher PM; Rusk AC
    Am J Med Genet; 1987 Apr; 26(4):851-61. PubMed ID: 3591827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women.
    Smith I; Elton RA; Thomson WH
    Clin Chim Acta; 1979 Nov; 98(3):207-16. PubMed ID: 498534
    [No Abstract]   [Full Text] [Related]  

  • 37. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and genetic counselling of subclinical and carrier states in Duchenne muscular dystrophy.
    Das PK; Sen SK
    Eur Neurol; 1979; 18(2):91-5. PubMed ID: 456392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA; Dubowitz V
    J Neurol Sci; 1981 Feb; 49(2):305-24. PubMed ID: 6452514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.